Thus, anti-ZnT8 antibodies have been shown to exist in the blood from the prediabetic phase and are likely a downstream event of the primary genetic pathogenesis of T1DM [117]. The gene discussed is SLC30A8; the disease is type 1 diabetes mellitus.